Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Cholecystolithiasis poses increased risks for renal transplant patients, due to metabolic changes and immunosuppressant use. Complications such as cholecystitis, cholangitis, and sepsis can adversely affect transplant outcomes. Data on its prevalence, clinical attributes, and outcomes remain limited. This study investigates the prevalence, management, and complications of cholecystolithiasis among renal transplant recipients at the National Kidney and Transplant Institute (2013–2018).
A retrospective study analyzed 1,537 renal transplant recipients’ records. Inclusion criteria were adult patients with documented cholecystolithiasis pre- or post-transplant and complete follow-up data. Data on demographics, cause of renal replacement therapy, and immunosuppressants were collected. Descriptive statistics summarized characteristics, while chi-square tests analyzed relationships between variables and outcomes, including gallstone development, complications, and adverse events.
The prevalence of cholecystolithiasis was 9.9% pre-transplant and 5.5% post-transplant. Older age (>41 years) significantly predicted gallstone formation (χ² = 23.818, p < 0.001), while diabetic nephropathy was the leading cause of renal failure in affected patients (χ² = 23.853, p < 0.001). Post-transplant complications, primarily cholecystitis, affected 10.5% of recipients with gallstones. Pre-existing gallstones significantly increased the risk of complications, including sepsis and cholangitis (χ² = 1068.839, p < 0.001). Immunosuppressant and steroid use showed no significant correlation with gallstone development (p > 0.05).
Elective cholecystectomy is advised for symptomatic and high-risk patients, such as older or diabetic recipients, to prevent complications. For asymptomatic, low-risk patients, conservative management with monitoring is suitable. Individualized assessments and multidisciplinary care are critical to improving post-transplant outcomes.
